Avilar Therapeutics
About:
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Website: https://www.avilar-tx.com/
Top Investors: RA Capital Management, Astellas Venture Management, Medical Excellence Capital, Sanofi Ventures
Description:
Avilar Therapeutics is a biopharmaceutical company focusing on the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.
Total Funding Amount:
$75M
Estimated Revenue Range:
$50M to $100M
Headquarters Location:
Waltham, Massachusetts, United States
Founded Date:
2020-01-01
Founders:
Daniel Grau, Milind Deshpande
Number of Employees:
11-50
Last Funding Date:
2023-02-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai